New England Journal of Medicine: Retatrutide Phase 2 trial results - The landmark study establishing retatrutide efficacy and safety across multiple dose groups New England Journal of Medicine: STEP 1 semaglutide trial results - The pivotal trial demonstrating semaglutide 2.4 mg weight loss efficacy ClinicalTrials.gov: Retatrutide TRIUMPH program - Current status and details of all ongoing Phase 3 retatrutide trials FDA prescribing information for Wegovy (semaglutide 2.4 mg) - Complete approved labeling including dosing, safety, and clinical data New England Journal of Medicine: SELECT cardiovascular outcomes trial - The trial demonstrating semaglutide 20% reduction in major cardiovascular events These primary sources should be the foundation for any serious evaluation of either compound
Step 5: Ongoing Support Stay connected through your success manager and health coaches for ongoing support, dose adjustments, and guidance throughout your weight-loss journey
Use precursors such as N-acetylcysteine (NAC), alpha-lipoic acid, and selenium to support the bodys natural glutathione production
Some individuals may experience bowel movements shortly after consuming a meal with fat
Thaw each aliquot only once Protect from light: Store in the original amber or opaque vial, or wrap in aluminum foil Keep the stopper sealed: Always replace the cap after each use to maintain sterility For comprehensive storage protocols across multiple compound classes, the complete peptide storage guide provides temperature charts and stability data for common research compounds